On-the-go coronavirus test maker gets $10 million NIH contract to scale up production

"The intent is really to be able to decentralize PCR testing and make it available to anyone who needs to get tested," medical device maker Visby CEO Adam de La Zerda told CNBC's Jim Cramer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.